CN Patent

CN105407883A — 控释药物制剂

Assigned to United Therapeutics Corp · Expires 2016-03-16 · 10y expired

What this patent protects

本发明公开一种包括通式(I)的前列环素的药物释放聚合物化合物和组合物以及对其进行制备的方法。优选的聚合物具有如下结构的重复单元：

USPTO Abstract

本发明公开一种包括通式(I)的前列环素的药物释放聚合物化合物和组合物以及对其进行制备的方法。优选的聚合物具有如下结构的重复单元：

Drugs covered by this patent

treprostinil-sodium (TREPROSTINIL SODIUM)

Patent Metadata

Patent number: CN105407883A
Jurisdiction: CN
Classification: —
Expires: 2016-03-16
Drug substance claim: No
Drug product claim: No
Assignee: United Therapeutics Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.